Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Lipid-Based Transfection in Primary Monocytes Within an Ex Vivo Whole-Blood Model. | Biomolecules | 2025 | 40149927 | PubTator, text mining | PubMed |
| Author Correction: Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells. | Genome Biol | 2025 | 40140907 | PubTator, text mining | PubMed |
| The changes of NLRs family members in the brain of AD mouse model and AD patients. | Front Immunol | 2025 | 40066444 | PubTator, text mining | PubMed |
| Transcriptomics and microbiome insights reveal the protective mechanism of mulberry-derived postbiotics against inflammation in LPS-induced mice. | Front Immunol | 2025 | 40040706 | PubTator, text mining | PubMed |
| Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma. | Blood Adv | 2025 | 40030008 | PubTator, text mining | PubMed |
| Polymorphisms in immunosuppression-related genes are associated with AML. | Front Immunol | 2025 | 39975548 | PubTator, text mining | PubMed |
| MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer. | PLoS One | 2025 | 39928678 | PubTator, text mining | PubMed |
High mobility group box-1 protein-mediated class II major histocompatibility complex transactivator superenhancers are critical for dendritic cell-trained immunity in acute-to-chronic progression of allograft rejection. | Am J Transplant | 2025 | 39884654 | PubTator, text mining | PubMed |
| Borrelia burgdorferi sensu lato inhibits CIITA transcription through pSTAT3 activation and enhanced SOCS1 and SOCS3 expression leading to limited IFN-γ production. | Ticks Tick Borne Dis | 2025 | 39879745 | PubTator, text mining | PubMed |
| LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells. | J Exp Clin Cancer Res | 2025 | 39856752 | PubTator, text mining | PubMed |
| An epigenetic pathway regulates MHC-II expression and function in B cell lymphoma models. | J Clin Invest | 2025 | 39817454 | PubTator, text mining | PubMed |
| RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma. | Clin Transl Med | 2025 | 39812592 | PubTator, text mining | PubMed |
| Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia. | Haematologica | 2025 | 39704147 | PubTator, text mining | PubMed |
| Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta-Analyses. | Arthritis Rheumatol | 2025 | 39679859 | PubTator, text mining | PubMed |
| Adenoviral delivery of the CIITA transgene induces T-cell-mediated killing in glioblastoma organoids. | Mol Oncol | 2025 | 39535369 | PubTator, text mining | PubMed |
| Machine learning-based identification and validation of immune-related biomarkers for early diagnosis and targeted therapy in diabetic retinopathy. | Gene | 2025 | 39427825 | PubTator, text mining | PubMed |
| Establishing a Ten Disulfidptosis-related Gene Signature for Prognostic Prediction in Skin Cutaneous Melanoma. | Comb Chem High Throughput Screen | 2025 | 38879775 | PubTator, text mining | PubMed |
| Region-Specific Transcriptional Signatures of Brain Aging in the Absence of Neuropathology at the Single-cell Level. | bioRxiv | 2025 | 37577533 | PubTator, text mining | PubMed |
| H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas. | bioRxiv | 2025 | 37398299 | PubTator, text mining | PubMed |
| ZBTB48 is a priming factor regulating B-cell-specific CIITA expression. | EMBO J | 2024 | 39562739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=7